Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Breast Neoplasms 26Lung Neoplasms 24Colonic Neoplasms 18Head and Neck Neoplasms 16Rectal Neoplasms 14Prostatic Neoplasms 11Sarcoma 10Neoplasm Metastasis 9Pancreatic Neoplasms 8Neoplasms 7Mouth Neoplasms 7Melanoma 7Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Ovarian Neoplasms 6Glioblastoma 6Precancerous Conditions 5Neuroblastoma 5Liver Neoplasms 5Central Nervous System Neoplasms 5Carcinoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Recurrence 4Oropharyngeal Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4

Interventions

Tobacco Use Cessation Devices 5Surveys and Questionnaires 4Standard of Care 3Exercise 3Ethanol 3Varenicline 2Tomography, X-Ray Computed 2Tobacco Products 2Smoking Devices 2Radiotherapy 2Motivational Interviewing 2Celecoxib 2zileuton 1olaparib 1Yoga 1Vitamin B 12 1Videotape Recording 1Transcranial Direct Current Stimulation 1Tablets 1Restraint, Physical 1Radon 1Psychiatric Rehabilitation 1Preoperative Exercise 1Practice Guidelines as Topic 1Phlebotomy 1Patient Navigation 1Nutritional Support 1Nicotine Replacement Therapy 1Nicotine 1Mindfulness-Based Stress Reduction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Smoking × Celecoxib × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed
219 enrolled

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡